MARY CARMON: Open Payments
NPI 1558781534 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,489 in 72 payments from 14 companies in 2025. Trend: 2023 $1,254 · 2024 $1,873 · 2025 $1,489
Food & beverage: $1,406Education: $83
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $275 |
| ABBVIE INC. | 15 | $274 |
| UCB, Inc. | 12 | $193 |
| Regeneron Healthcare Solutions, Inc. | 8 | $173 |
| Organogenesis Inc. | 14 | $152 |
| Galderma Laboratories, L.P. | 1 | $100 |
| LEO Pharma Inc. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $58 |
| GENZYME CORPORATION | 1 | $26 |
Products named: TREMFYA, DUPIXENT, Bimzelx, SKYRIZI, RINVOQ, NEMLUVIO, CYGNUS DUAL, ILUMYA.
Industry payments across FL — which companies pay providers there.
